| Patents for A61P 39 - General protective or antinoxious agents (19,019) |
|---|
| 05/06/2004 | EP1019067B1 Methods of using emu oil and active fractions thereof as an insect repellent |
| 05/04/2004 | US6730692 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 04/29/2004 | WO2004035026A1 Deferacirox dispersible tablets |
| 04/29/2004 | WO2004011402A3 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 04/29/2004 | WO2003020949A3 Targeted nucleic acid constructs and uses related thereto |
| 04/29/2004 | US20040081734 Obtaining a balanced enriched composition of simple phenols, polyphenols, bioflavonoids, flavones and flavonones, to control oxidation processes, from citrus aqueous extracts |
| 04/29/2004 | US20040081715 Cholesterol reducing confectionery comprising a cocoa procyanidin monomer and/or oligomer and a sterol and/or stanol based cholesterol lowering agent |
| 04/29/2004 | US20040081714 Cosmetic and/or pharmaceutical preparations |
| 04/29/2004 | DE10294485T5 Mit Mnk-Kinase homologe Proteine, die in die Regulation der Energiehomöostase und den Organellenmetabolismus involviert sind Mnk homologous proteins with kinase, that are involved in the regulation of energy homeostasis and the metabolism organelle |
| 04/28/2004 | EP1412490A1 Mediating the effects of alcohol consumption by orally administering active dry yeast |
| 04/28/2004 | EP1412486A2 Method for virus propagation |
| 04/28/2004 | EP1412379A2 Antigenic polypeptides |
| 04/28/2004 | EP1411986A1 Composition for epigallocatechin gallate |
| 04/28/2004 | EP1411912A1 Treatment of chronic pain with 3-aryloxy-3-phenylpropanamines |
| 04/28/2004 | EP1411910A1 (+)-cycloolivil as antioxidant obtained from stereospermum personatum |
| 04/28/2004 | EP1411909A1 Pharmaceutical composition comprising (-)-secoisolariciresinol |
| 04/28/2004 | EP1411889A1 Cream for treatment of skin injured by the sun |
| 04/28/2004 | EP1411879A1 A composition and uses therefor for combating hangover |
| 04/28/2004 | EP1162981B1 Dexrazoxane for the treatment of accidental extravasation of anthracyclines |
| 04/28/2004 | EP1042313B1 Benzopyran and benzothiopyran derivatives having retinoid antagonist like activity |
| 04/28/2004 | CN1492737A Functional agent for decomposing nicotine and method of preparing the same |
| 04/28/2004 | CN1147495C Alkyl-4-silylheterocyclic phenols and thiophenols as antioxidant agents |
| 04/27/2004 | US6727275 Pyrrolidinone derivatives |
| 04/27/2004 | US6727253 Use of a topo ii catalytic nhibitor such as the bisdioxopiperazine icrf-187, a quinoline, aclarubicin, and an acridine. |
| 04/27/2004 | US6727239 Inhibitory activity on no- synthase enzymes producing nitrogen monoxide no and/or an activity which traps the reactive oxygen species (ros) |
| 04/27/2004 | US6727227 Cause an increase in superoxide dismutase activity in said subject |
| 04/27/2004 | US6727226 Conotoxin peptide extracted from the venom of a marine snail, conus magnus (cono=cone); disorders associated with voltage gated sodium ion channel; neuromuscular blocking agents; local anesthetics; neuroprotective agents; analgesics |
| 04/27/2004 | US6727075 Measuring lipid peroxidation in mammals; obtain tissue or fluid sample evaluate the concentration of prostaglandin isomer marker present, compare to control, amplified concentration of the marker indicates oxidative stress |
| 04/22/2004 | WO2004032948A1 Extract with anti-tumor and anti-poisonous activity |
| 04/22/2004 | WO2004032947A1 Extract with anti-tumor and anti-poisonous activity |
| 04/22/2004 | WO2004032832A2 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/22/2004 | US20040077842 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 04/22/2004 | US20040077702 Administering indazole derivative; or thienyl-, furyl-, or pyrrolyl- fused pyrazole derivative to treat Alzheimer*s, Parkinson*s, or Huntington*s disease |
| 04/22/2004 | US20040077667 Quinazolinone derivatives |
| 04/22/2004 | US20040076692 Mixtures of xanthine oxidase inhibitors and free radical scavangers, used as antiischemic agents or for prophylaxis of cardiovascular disorders |
| 04/22/2004 | US20040076614 For natural cellular immune defense in humans/animals; for foods/feeds |
| 04/22/2004 | CA2501240A1 Extract of the plant calotropis procera with anti-tumor and anti-poisonous activity |
| 04/22/2004 | CA2499081A1 Bispecific molecule comprising an anti-cr1 antibody cross-linked to an antigen-binding antibody fragment |
| 04/21/2004 | EP1410798A2 Treatment and prevention of reactive oxygen metabolite-mediated cellular damage |
| 04/21/2004 | EP1409535A2 Human secreted proteins |
| 04/21/2004 | EP1408999A1 Compositions addressing inflammation and/or degenerative disorders |
| 04/21/2004 | EP1408998A2 Kefir as a potent anti-oxidant composition |
| 04/21/2004 | EP1408947A2 Fumaric acid derivatives as nf-kappab inhibitors |
| 04/21/2004 | EP1408921A1 Composition for oral hygiene comprising a fluoride ion vector and an antioxidant |
| 04/21/2004 | EP0939654B1 Use of no syntase inhibitors with scavengers of oxygen reactive forms for the treatment of ischemia |
| 04/21/2004 | CN1491089A Composition and method for smoke detoxification |
| 04/21/2004 | CN1490329A Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses |
| 04/21/2004 | CN1490328A Imidazoline substituted phenoxyacetyl oligopeptide compounds, their synthesis and medical uses |
| 04/21/2004 | CN1146553C Hydroxymatatairesinol in cancer prevention |
| 04/21/2004 | CN1146428C Crystallized pirimiphos-methyl composite and its preparation and usage |
| 04/21/2004 | CN1146415C Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 04/20/2004 | US6723747 Estrogen receptor modulators useful in treating or inhibiting conditions, disorders, or disease states at least partially mediated by estrogen deficiency or excess, or which may be treated or inhibited through use of estrogenic agent |
| 04/20/2004 | US6723742 Substituted 3,5-diphenyl-1,2,4-triazoles and their use as pharmaceutical metal chelators |
| 04/20/2004 | US6723372 Spraying grains which consist of a prostane derivative and a cyclodextrin vehicle, forming together a prostane-cyclodextrine-clathrate, with an aqueous polymer dispersion of ethyl cellulose and/or poly(methyl)acrylic acid ester |
| 04/15/2004 | WO2004006836A3 Treatment of neuropathic pain with 6h-pyrrolo[3,4-d]pyridazine compounds |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003103567A3 Nitrosodiphenylamine derivatives, compositions comprising them, and the use thereof as antioxidants and spontaneous nitric oxide donors |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | US20040071766 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 04/15/2004 | DE10296335T5 Pharmazeutische Formulierungen Pharmaceutical formulations |
| 04/14/2004 | EP1406879A1 Novel chelating agents and conjugates thereof, their synthesis and use as diagnostic and therapeutic agents |
| 04/14/2004 | EP1406859A1 Substituted 4-aminocyclohexanol derivatives |
| 04/14/2004 | EP1406664A2 Targeting chemical compounds to cells |
| 04/14/2004 | EP1406650A1 Use of poly-glu, tyr and t cells treated therewith for neuroprotection therapy |
| 04/14/2004 | EP1406609A2 Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/14/2004 | EP1406608A2 Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use |
| 04/14/2004 | EP1406602A2 Use of sulfonyl aryl or heteroaryl hydroxamic acids and derivatives thereof as aggrecanase inhibitors |
| 04/14/2004 | EP1039917B1 Pharmaceutical composition comprising ticlopidine and ginkgo biloba extract |
| 04/14/2004 | EP0935465B1 Novel substituted imidazole compounds |
| 04/14/2004 | CN1489590A Compounds specific to adenosine A1, A2, and A3 receptor and uses thereof |
| 04/14/2004 | CN1489581A 喹唑啉酮衍生物 Quinazolinone derivatives |
| 04/14/2004 | CN1488353A Composition for treating ischemic disease |
| 04/13/2004 | US6720337 Antitumor agents; synergistic mixtures; side effect reduction |
| 04/13/2004 | CA2292248C Novel derivatives of 1,2-dithiolane, process for preparing them and pharmaceutical compositions containing them |
| 04/08/2004 | WO2003084521A3 Use of conjugated estrogens in combination with trimegestone in hormone replacement therapy |
| 04/08/2004 | WO2003018606A9 Casein derived peptides and uses thereof in therapy |
| 04/08/2004 | US20040067894 Preparation having antioxidant properties |
| 04/07/2004 | EP1404665A1 Antimicrobial and radioprotective compounds |
| 04/07/2004 | EP1404330A1 Substituted 8-arylquinoline pde4 inhibitors |
| 04/07/2004 | EP1404324A2 Prodrugs of gaba analogs, compositions and uses thereof |
| 04/07/2004 | EP1404310A1 Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
| 04/07/2004 | EP1404295A2 Sustained release drug delivery devices with coated drug cores |
| 04/07/2004 | EP1404174A2 Anti-infective compositions for treating disordered tissue such as cold sores |
| 04/07/2004 | EP0596032B2 Induction of cytotoxic t-lymphocyte responses |
| 04/07/2004 | CN1487923A Process for the preparation of (3-cyano-1H-indol-7-yl) (4-(4-fluorophenethyl)piperazin-1-yl)-methanone and salts thereof |
| 04/07/2004 | CN1487840A Molecular antigen array |
| 04/07/2004 | CN1487838A Molecular antigen array |
| 04/07/2004 | CN1486700A Proanthocyanidin compound and its prepn |
| 04/07/2004 | CN1144587C Agents for relieving side effects |
| 04/07/2004 | CN1144584C Sustained-release compositions and method for preparing the same |
| 04/06/2004 | US6717012 Such as alpha-phenyl-n-(7-tert-butoxycarbonylamino-3,5-dimethyladamantane)nitrone for treatment of neurological/ inflammatory diorders, and aging, which result from the overproduction of nitric oxide |
| 04/06/2004 | US6716818 Caspase inhibitors and the use thereof |
| 04/06/2004 | CA2404810C Topical composition having undifferentiated plant seed cells and method for using same |
| 04/06/2004 | CA2060616C Use of 4-(3-trifluoromethylphenyl)-1,2,3,6-tetrahydropyridine derivatives as free radical scavengers |
| 04/01/2004 | WO2003099256A3 FREE-FLOWING, POWDERY COMPOSITION CONTAINING α-LIPONIC ACID (DERIVATIVES) |
| 04/01/2004 | WO2003066021A3 Drug nanoparticles with lysozyme surface stabiliser |
| 04/01/2004 | WO2003049675A3 Treating muscle wasting with selective androgen receptor modulators |
| 04/01/2004 | WO2002085897A9 Heterocyclic compounds for aging-related and diabetic vascular complications |